FDA approves treatment for bacterial vaginosis (News-Medical-Net)
Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

FDA Says FluMist Vaccine Facility Still Not In Compliance (KOLR/KSFX Ozarks)
(Washington, DC) -- A flu vaccine manufactured in Britain by Maryland-based MedImmune remains intact despite FDA concerns over contamination at the plant.